Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug 21;16(8):e67377.
doi: 10.7759/cureus.67377. eCollection 2024 Aug.

Advances in Type 1 Diabetes Mellitus Management in Children

Mridu Bahal  1 , Vineeta Pande  1 , Jasleen Dua  1 , Shailaja Mane  1
Affiliations
Review

Advances in Type 1 Diabetes Mellitus Management in Children

Mridu Bahal et al. Cureus. .

Abstract

Recent advancements in the management of type 1 diabetes mellitus (T1DM) have significantly improved outcomes and quality of life for patients, particularly children. Technological innovations, such as continuous glucose monitoring (CGM) systems and insulin pump therapy, including hybrid closed-loop systems, have enhanced glycemic control by providing real-time data and automated insulin delivery. Ultrarapid-acting insulins and adjunctive pharmacotherapies, like sodium-glucose transport protein 2 (SGLT2) inhibitors and glucagon-like peptide 1 (GLP-1) receptor agonists, offer improved postprandial glucose management and reduced insulin requirements. Immunotherapy and beta-cell replacement therapies, including stem cell research and encapsulation devices, aim to preserve or restore endogenous insulin production. Digital health platforms and telemedicine have expanded access to education and support, fostering better self-management. Future directions in precision medicine, artificial intelligence, and microbiome research hold promise for personalized and potentially curative treatments. Collectively, these advances are transforming T1DM management, reducing disease burden, and enhancing the prospects for children with T1DM.

Keywords: diabetes research; diabetes type 1; endocrinology and diabetes; pediatric diabetes; type i diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Similar articles

See all similar articles

References

    1. Lucier J, Weinstock RS. Vol. 3. Treasure Island (FL): StatPearls Publishing; 2024. Type 1 Diabetes; p. 2024.
    1. Type 1 diabetes. Atkinson MA, Eisenbarth GS, Michels AW. Lancet. 2014;383:69–82. - PMC - PubMed
    1. Diabetes distress in Indian children with type 1 diabetes mellitus and their mothers. Lohiya NN, Kajale NA, Lohiya NN, Khadilkar VV, Gondhalekar K, Khadilkar A. J Pediatr Endocrinol Metab. 2021;34:209–216. - PubMed
    1. 6. Glycemic targets: standards of medical care in diabetes-2020. American Diabetes Association. Diabetes Care. 2020;43:0–76. - PubMed
    1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. Nathan DM, Genuth S, Lachin J, et al. N Engl J Med. 1993;329:977–986. - PubMed

LinkOut - more resources